A year after Abcuro raised $200 million to fund a phase 2/3 muscle disease trial of its anti-KLRG1 antibody, the study has ...
Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients ages 2 to 17, who had an inadequate ...
SHANNON, CLARE, IRELAND, February 5, 2026 /EINPresswire.com/ -- A new publication from Opto-Electronic Technology; DOI ...
Council Approves Rezoning After Public Hearing, Addresses Parking and Park Concerns Residential development continues to push ...
Scientists at Microsoft Research in the United States have demonstrated a system called Silica for writing and reading ...
Q4 2025 Earnings Call February 23, 2026 4:45 PM ESTCompany ParticipantsRhonda Bennetto - Senior Vice President of ...
From limited, task-specific automation to sophisticated Cognitive Intelligence Platforms (CIPs), artificial intelligence has undergone tremendous ...
RISC-V’s expanding role in AI is not a rejection of incumbent architectures, which continue to deliver performance and ...
At CES, MPS highlighted how its motor-control ICs can enable smarter, more precise control of brushless DC motors that are multiplying across robotics and other industries.
Eisai remains deeply committed to a patient-centered approach in Alzheimer's care and ensuring LEQEMBI (R) is available to those eligible and living with early AD in Canada. We will continue to pursue ...
Their electoral setback reduces the leverage of maximalist narratives and creates more room for a pragmatic reset in Dhaka’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results